Full Text
PCN230 - ARE NICE AND THE SMC DIVERGING IN THEIR ASSESSMENT OF ONCOLOGY DRUGS?

Abstract

Authors

R. Macaulay A. Berardi G.D. Wang I. Kasli

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×